Rigaku Announces Reorganization
News Oct 18, 2005
Rigaku has announced reorganization whereby the various operating companies and divisions of Rigaku, serving markets external to Japan and its core sales territories, began to operate as a single company.
As of September 1, 2005, Rigaku Americas Corporation (RAC) became the operating entity in charge of North America.
Over the last decade, Rigaku has acquired or founded a number of companies in order to develop a technology portfolio capable of sustained innovation for core markets.
During this period of high growth, the new additions retained their individual company identities.
With key capabilities now in place, top level integration will maximize the quality of solutions available to our customers while expediting the rollout of new advances.
Henceforth, all marketing and advertising material will brand the company solely as “Rigaku."
The new, combined organization (RAC) includes: Rigaku/MSC, Osmic, RoboDesign, Molecular Images, Electronic Imaging Technologies, Molecular Metrology, and the Vacuum Products division.
ActiveSight, Rigaku’s contract research organization (CRO), servicing the pharmaceutical and biotech markets, will continue to operate as a separate entity. The former Rigaku/MSC operation in the U.K will now be known as Rigaku Europe.
From a legal and formal standpoint, the transition will take place over the next few months, with the completion targeted for March 1, 2006.
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE